World High Life Plc (“World High Life” or the “Company”)(AQSE:LIFE)(OTCQB:WRHLF) is pleased to announce that its wholly owned subsidiary, leading UK-based CBD brand, Love Hemp Limited, (“Love Hemp”), has submitted its Novel Food dossier to the Food Standards Agency (“FSA
The dossier submitted by Love Hemp is in support of the FSA’s move to regulate a currently unregulated CBD market in the UK.
Tony Calamita, CEO of World High Life and Love Hemp, says “We are committed to providing our consumers with the highest quality THC-free CBD products and believe the new Novel Food regulations will help end regulatory uncertainty surrounding CBD in the UK.”
Dr. Sepe Sehati, Chief Scientific and Regulatory Affairs Lead at Love Hemp, says “It’s been a huge pleasure to spend the past few months leading a dedicated team to compile a robust evidence-based dossier for submission to the FSA. To my knowledge, Love Hemp’s application is also in the unique position of having provided comprehensive pre-clinical results, based on our own proprietary study protocols, investigating the effects of Love Hemp’s finished product formulations on the pharmacokinetics of CBD. To have been able to do this at pre-validation stage is a great achievement.”
The Directors of the Company accept responsibility for the contents of this announcement.
About Love Hemp
Love Hemp is one of the UK’s leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,500 stores in the UK, including leading brands such as Sainsbury’s, Boots, Ocado and Holland & Barrett.
About World High Life
World High Life was established by the founders of Supreme Cannabis (TSX: FIRE), and 1933 Industries (CSE: TGIF), both companies at the forefront of the legalized cannabis industry. LIFE was established to take advantage of the huge opportunities available in the UK and European legal cannabis space, which is set to be the largest in the world within five years.
For further information please contact:
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
SOURCE: World High Life Plc
View source version on accesswire.com:
News Provided by ACCESSWIRE via QuoteMedia
World High Life Plc
Pineapple Express Delivery Partners with CannTrust to Offer Same-Day and Next-Day Delivery for estoraTM Medical Cannabis Patients in Ontario
Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products
World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.